Annual ROE
518.49%
+670.05%+442.10%
December 31, 2023
Summary
- As of February 12, 2025, EIGR annual return on equity is 518.49%, with the most recent change of +670.05% (+442.10%) on December 31, 2023.
- During the last 3 years, EIGR annual ROE has risen by +586.94% (+857.47%).
- EIGR annual ROE is now at all-time high.
Performance
EIGR ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-869.84%
-632.51%-266.51%
December 31, 2023
Summary
- As of February 12, 2025, EIGR quarterly return on equity is -869.84%, with the most recent change of -632.51% (-266.51%) on December 31, 2023.
- Over the past year, EIGR quarterly ROE has dropped by -750.72% (-630.22%).
- EIGR quarterly ROE is now -11914.36% below its all-time high of -7.24%, reached on June 30, 2016.
Performance
EIGR Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
EIGR ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +442.1% | -630.2% |
| 3 y3 years | +857.5% | -868.4% |
| 5 y5 years | +759.1% | -582.3% |
EIGR ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +442.1% | -2424.9% | at low |
| 5 y | 5-year | at high | +442.1% | -3841.3% | at low |
| alltime | all time | at high | +336.1% | <-9999.0% | at low |
Eiger BioPharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | 518.49%(-442.1%) | -869.84%(+266.5%) |
| Sep 2023 | - | -237.33%(+42.3%) |
| Jun 2023 | - | -166.73%(+27.0%) |
| Mar 2023 | - | -131.31%(+10.2%) |
| Dec 2022 | -151.56%(+274.1%) | -119.12%(+12.3%) |
| Sep 2022 | - | -106.06%(+12.9%) |
| Jun 2022 | - | -93.93%(+8.3%) |
| Mar 2022 | - | -86.77%(+151.9%) |
| Dec 2021 | -40.51%(-40.8%) | -34.45%(+16.8%) |
| Sep 2021 | - | -29.49%(+27.8%) |
| Jun 2021 | - | -23.07%(+4.5%) |
| Mar 2021 | - | -22.07%(-75.4%) |
| Dec 2020 | -68.45%(-45.0%) | -89.82%(-10.7%) |
| Sep 2020 | - | -100.60%(-12.5%) |
| Jun 2020 | - | -115.03%(+9.2%) |
| Mar 2020 | - | -105.31%(+0.1%) |
| Dec 2019 | -124.38%(+58.1%) | -105.24%(+4.4%) |
| Sep 2019 | - | -100.79%(-11.8%) |
| Jun 2019 | - | -114.29%(-5.7%) |
| Mar 2019 | - | -121.23%(-4.9%) |
| Dec 2018 | -78.67% | -127.49%(-18.0%) |
| Sep 2018 | - | -155.55%(-0.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | -156.66%(-31.1%) |
| Mar 2018 | - | -227.24%(+15.9%) |
| Dec 2017 | -188.47%(+63.0%) | -196.02%(+15.9%) |
| Sep 2017 | - | -169.14%(+31.2%) |
| Jun 2017 | - | -128.94%(+11.2%) |
| Mar 2017 | - | -115.92%(+17.2%) |
| Dec 2016 | -115.63%(+173.9%) | -98.87%(+462.1%) |
| Sep 2016 | - | -17.59%(+143.0%) |
| Jun 2016 | - | -7.24%(-52.9%) |
| Mar 2016 | - | -15.37%(-51.3%) |
| Dec 2015 | -42.22%(-10.1%) | -31.55%(-67.6%) |
| Sep 2015 | - | -97.42%(+17.2%) |
| Jun 2015 | - | -83.09%(+24.7%) |
| Mar 2015 | - | -66.63%(+26.6%) |
| Dec 2014 | -46.95%(-78.6%) | -52.64%(-10.9%) |
| Sep 2014 | - | -59.09%(-23.5%) |
| Jun 2014 | - | -77.24%(-14.0%) |
| Mar 2014 | - | -89.86%(-23.8%) |
| Dec 2013 | -219.56%(+233.3%) | -117.93%(+78.2%) |
| Sep 2013 | - | -66.17%(+62.0%) |
| Jun 2013 | - | -40.85% |
| Dec 2012 | -65.88%(-1734.7%) | - |
| Dec 2011 | 4.03% | - |
FAQ
- What is Eiger BioPharmaceuticals annual return on equity?
- What is the all time high annual ROE for Eiger BioPharmaceuticals?
- What is Eiger BioPharmaceuticals annual ROE year-on-year change?
- What is Eiger BioPharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Eiger BioPharmaceuticals?
- What is Eiger BioPharmaceuticals quarterly ROE year-on-year change?
What is Eiger BioPharmaceuticals annual return on equity?
The current annual ROE of EIGR is 518.49%
What is the all time high annual ROE for Eiger BioPharmaceuticals?
Eiger BioPharmaceuticals all-time high annual return on equity is 518.49%
What is Eiger BioPharmaceuticals annual ROE year-on-year change?
Over the past year, EIGR annual return on equity has changed by +670.05% (+442.10%)
What is Eiger BioPharmaceuticals quarterly return on equity?
The current quarterly ROE of EIGR is -869.84%
What is the all time high quarterly ROE for Eiger BioPharmaceuticals?
Eiger BioPharmaceuticals all-time high quarterly return on equity is -7.24%
What is Eiger BioPharmaceuticals quarterly ROE year-on-year change?
Over the past year, EIGR quarterly return on equity has changed by -750.72% (-630.22%)